News

Moderna plans to slash 10% of workforce as COVID shot sales slow
Massachusetts-based Moderna said it plans to cut 10% of its global staff as part of its ongoing efforts to reduce annual operating expenses by around $1.5 billion by 2027.
Cambridge-based Moderna announces plan to cut workforce by 10%
The Cambridge-based vaccine maker, which became a household name during the pandemic, is cutting its global workforce to under 5,000 employees.
Moderna Slashes Global Workforce by 10% as $1.5B Cost Cuts Hit Home
Moderna is downsizing its workforce by 10% globally to bring headcount to under 5,000 in “a difficult moment for the company,” CEO Stéphane Bancel told employees in a note Thursday morning.
Moderna plans to lay off 10% of workforce to cut costs
Moderna said on Thursday it would trim roughly 10% of its global workforce and have fewer than 5,000 employees by the end of the year as the biotech accelerates its cost-cutting efforts amid declining sales of COVID-19 vaccines.
Moderna Falls as Cost-Cutting Fails to Appease Investors
Moderna Inc. shares declined as the company’s cost-cutting efforts failed to assuage investors who are worried about the decline of its Covid vaccine business.
Moderna lays off 500 in latest cost-cutting move
The layoffs are part of an ongoing effort to reduce operating costs amid government and competitive challenges to its vaccine business.
Cambridge-based Moderna to cut about 10% of its workforce
Massachusetts-based Moderna, one of the companies at the forefront of developing a vaccine during the COVID pandemic, announced Thursday that it will lay off about 10% of its workforce.
Moderna to lay off 10% of workforce
Moderna said Thursday it plans to reduce the size of its workforce by 10% globally. Moderna CEO Stephane Bancel said in a memo to employees that the company expects to reduce its workforce to fewer than 5,
Moderna to cut 10 percent of workforce
The reduction of people getting COVID vaccines is hitting Moderna. It plans to cut some of its workforce by the end of the year.
Moderna to lay off 10% of staff this year
Moderna (MRNA) stock in focus as the company plans to cut 10% of its workforce by 2025 amid cost-saving efforts. Read more here.
BioSpace2d

Moderna’s Bancel Nay on M&A, Yay on R&D Partnerships

It’s not often that a CEO outright dismisses M&A prospects, but Moderna CEO Stéphane Bancel says the mRNA biotech has enough ...
Pharmaceutical Technology on MSN1d

Moderna sharpens focus on $1.5bn cost cutting plan after 41% revenue slump

"Moderna sharpens focus on $1.5bn cost cutting plan after 41% revenue slump" was originally created and published by ...

Moderna is laying off 10% of its workforce. Does RFK Jr. have anything to do with it?

The biotech company’s revenue halved in 2024, and it continues to face uncertainty in the vaccine market. Biotech giant ...
BioPharma Dive2d

Moderna to lay off 10% of workforce in ‘difficult but necessary step’

In a memo, CEO Stéphane Bancel said the job cuts are needed to align the struggling vaccine maker’s cost structure with the ...
Stocktwits on MSN2d

Moderna CEO Attributes Full-Year Revenue Guidance Reduction To Timing Of Shipments: Retail Pins Hopes On Pipeline After Q2 Beat

CEO Stéphane Bancel on Friday stated that the company is lowering its annual revenue forecast due to the timing of shipments despite the company’s upbeat second-quarter numbers. The vaccine maker ...

Moderna will lay off 10% of employees, Massachusetts-based company announces

Massachusetts-based Moderna, one of the companies at the forefront of developing a vaccine during the COVID pandemic, ...

Moderna to Cut 10% of Staff to Offset Slowing Covid Business

Moderna Inc. is cutting about 10% of its workforce, part of an effort by the struggling biotech company to reduce spending as ...
FiercePharma2y

Moderna CEO Stéphane Bancel gets a $1.2M bump in pay to $19.4M

After another year of transformational revenue from the company's COVID-19 vaccine, Moderna has rewarded CEO Stéphane Bancel with a pay package of $19.4 million, according to a proxy statement ...
STAT2y

Bancel, Sanders spar over what Moderna owes the government

Moderna CEO Stéphane Bancel and Sen. Bernie Sanders sparred over how much the company owes the federal government for its investment in developing the company’s Covid-19 vaccine.

Vaccine maker Moderna cuts hundreds of jobs; CEO says 'every effort' made to avoid layoffs

Moderna CEO Stéphane Bancel said in an email to employees that the company made "every effort" to avoid layoffs that will ...